ADDvise Group

ADDvise Group’s interim report for the period January 1 – June 30, 2024 will be published on July 18, 2024 at 07:45 (CEST).

Investors, analysts, and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.

Webcast

If you wish to participate via webcast, please use the link below.

https://ir.financialhearings.com/addvise-group-q2-report-2024/register

Conference call

If you wish to participate via conference call, please register via the link below. After registration you will receive a phone number and conference ID to access the conference.

https://conference.financialhearings.com/teleconference/?id=50048645

The report and a link to the webcast will be made available on:

https://www.addvisegroup.com/investor-relations/

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Oliver Humlen, CFO
+46 709-16 26 97
oliver.humlen@addvisegroup.se

About ADDvise

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. More information is available at www.addvisegroup.com.